XML 31 R19.htm IDEA: XBRL DOCUMENT
v3.25.2

Research and Development Expenses | 12 Months Ended
--- | ---
Jun. 30, 2025
Disclosure Of Research And Development Expenses [Abstract] |
Research and Development Expenses | Note 9. Research and Development Expenses
|  | 2025 |  |  | 2024 |  |  | 2023 |
|  | US$(000's) |  |  | US$(000's) |  |  | US$(000's) |
Employee benefits expenses: |  |  |  |  |  |  |  |  |
Salaries and fees |  |  | 10,211 |  |  |  | 4,809 |  |  |  | 3,756 |
Severance |  |  | 4,544 |  |  |  | — |  |  |  | — |
Cash bonuses |  |  | 1,741 |  |  |  | 1,425 |  |  |  | 445 |
Superannuation |  |  | 361 |  |  |  | 182 |  |  |  | 120 |
Share-based payments expense |  |  | 883 |  |  |  | 1,300 |  |  |  | 1,909 |
Total employee benefits expense |  |  | 17,740 |  |  |  | 7,716 |  |  |  | 6,230 |
Payroll tax |  |  | 782 |  |  |  | 295 |  |  |  | 208 |
Research Insurance |  |  | 255 |  |  |  | 322 |  |  |  | 262 |
Research project costs 1 |  |  | 108,055 |  |  |  | 167,993 |  |  |  | 122,128 |
Total research and development expenses |  |  | 126,832 |  |  |  | 176,326 |  |  |  | 128,828 |
1. The research project costs relate to the research programs in respect to the treatment of eye diseases by sozinibercept.

X
- Definition Disclosure of research and development expenses. + References No definition available. + Details
Name: | opt_DisclosureOfResearchAndDevelopmentExpensesAbstract
Namespace Prefix: | opt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for research and development expenses. + References No definition available. + Details
Name: | opt_DisclosureOfResearchAndDevelopmentExpensesExplanatory
Namespace Prefix: | opt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration